Biodistribution of GB-10 (Na210B10H 10) compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch

Archives of Oral Biology

Volumn 49, Issue 4, 2004, Pages 313-324

  Heber, Elisa ^a   Trivillin, Verónica A ^a   Nigg, David ^b   Kreimann, Erica L ^a   Itoiz, Maria E ^a,c   Rebagliati, Raúl J ^a   Batistoni, Daniel ^a   Schwint, Amanda E ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b IDAHO NATIONAL LABORATORY   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

BNCT; GB 10; Hamster cheek pouch; Oral cancer

Indexed keywords

4 DIHYDROXYBORYLPHENYLALANINE; 4-DIHYDROXYBORYLPHENYLALANINE; BORON DERIVATIVE; DRUG DERIVATIVE; PHENYLALANINE; RADIOSENSITIZING AGENT;

ANIMAL; ANIMAL MODEL; ARTICLE; CHEEK; DRUG COMBINATION; DRUG INTERACTION; HAMSTER; METABOLISM; METHODOLOGY; MOUTH TUMOR; NEUTRON CAPTURE THERAPY; PRECANCER;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CHEEK; CRICETINAE; DRUG COMBINATIONS; DRUG INTERACTIONS; MODELS, ANIMAL; MOUTH NEOPLASMS; PHENYLALANINE; PRECANCEROUS CONDITIONS; RADIATION-SENSITIZING AGENTS;

CRICETINAE;

EID: 1542380383     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2003.10.003     Document Type: Article

References (44)

1. Locher G.L. Biological effects and therapeutic possibilities of neutrons. Am. J. Roentgenol. 36:1936;1-13.
2. Taylor H.J., Goldhaber M. Detection of nuclear disintegration in a photographic emulsion. Nature (Lond). 135:1935;341-348.
3. Gabel D., Fairchild R.G., Larsson B. The relative biological effectiveness in V79 Chinese hamster cells of the neutron capture reaction in boron and nitrogen. Radiat. Res. 98:1984;307-316.
4. Coderre J., Glass J.D., Fairchild R.G., Micca P.L., Joel D.D. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma. Cancer Res. 50:1990;138-141.
5. Coderre J.A., Morris G.M. The radiation biology of boron neutron capture therapy. Radiat. Res. 151:1999;1-18.
6. Coderre J.A., Chanana A.D., Joel D.D., Elowitz E.H., Micca P.L., Nawrocky M.M.et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat. Res. 149:1998;163-170.
7. Coderre J.A., Morris G.M., Kalef-Ezra J., Micca P.L., Ma R., Yangs K.et al. The effects of boron neutron capture therapy irradiation on oral mucosa: evaluation using a rat tongue model. Radiat. Res. 152:1999;113-118.
8. Hatanaka H., Nakagawa Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;1061-1066.
9. 11SH (BSH) in patients with malignant brain tumors as prerequisite for a Phase I clinical trial of boron neutron capture therapy. Acta Neurochir. 139:1997;606-612.
10. Chanana D., Capala J., Chadha M., Coderre J.A., Diaz A.Z., Elowitz E.H. et al. Boron neutron capture therapy for glioblastoma multiforme: interim results for the Phase I/II dose-escalation studies. Neurosurgery. 44:1999;1182-1193.
11. Barth R.F., Matalka K.Z., Bailey M.Q., Staubus A.E., Soloway A.H., Moeschberger M.L.et al. A nude rat model for neutron capture therapy of human intracerebral melanoma. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;1079-1088.
12. Coderre J.A., Slatkin D.N., Micca P.L., Ciallella J.R. Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index. Radiat. Res. 128:1991;177-185.
13. Coderre J.A., Joel D.D., Micca P.L., Nawrocky M.M., Slatkin D.N. Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. Radiat. Res. 129:1992;290-296.
14. Coderre J.A., Button T.M., Micca P.L., Fisher C.D., Nawrocky M.M., Liu H.B. Neutron capture therapy of the 9L rat gliosarcoma using the boronophenlyalanine-fructose complex. Int. J. Radiat. Oncol. Phys. 30:1994;643-652.
15. Matalka K.Z., Bailey M.Q., Barth R.F., Staubus A.E., Soloway A.H., Moeschberger M.L.et al. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent. Cancer Res. 53:1993;3308-3313.
16. Barth R.F., Yang W., Rotaru J.H., Moeschberger M.L., Joel D.D., Nawrocky M.M.et al. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. Cancer Res. 57:1997;1129-1136.
17. Barth R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neuro-Oncol. 36:1998;91-102.
18. Kreimann E.L., Itoiz M.E., Dagrosa A., Garavaglia R., Farías S., Batistoni D.et al. The Hamster Cheek Pouch as a Model of Oral Cancer for Boron Neutron Capture Therapy Studies: Selective Delivery of Boron by Boronophenlyalanine. Cancer Res. 61:2001;8775-8781.
19. Kreimann E.L., Itoiz M.E., Longhino J., Blaumann H., Calzetta O., Schwint A.E. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer Res. (Adv. Brief). 61:2001;8638-8642.
20. Kreimann E.L., Miura M., Itoiz M.E.et al. Biodistribution of a carborane-containing porphyrin as a targeting agent for boron neutron capture therapy of oral cancer in the hamster cheek pouch. Arch. Oral Biol. 48(3):2003;223-232.
21. Salley J.J. Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J. Dent. Res. 33:1954;253-262.
22. Morris L. Factors influencing experimental carcinogenesis in the hamster cheek pouch. J. Dent. Res. 40:1961;3-15.
23. Cahan W.G. Multiple primary cancers of the lung. Cancer (Phila). 40:1997;1954-1960.
24. Dhooge J., De-Vos M., Van-Cauwenberge P.B. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope. 108:1998;250-256.
25. Smith D., Haffty B.G. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat. Oncol. Investig. 7:1999;125-144.
26. Slaughter P., Southwick H.W., Smejtal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila). 6:1953;963-968.
27. Khuri F.R., Lippman S.M., Spitz M.R., Lotan R., Hong W.K. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J. Natl. Cancer Inst. 89:1997;199-211.
28. Fu K.K., Cooper J.S., Marcial V.A., Laramore G.E., Pajak T.F., Jacobs J.et al. Evolution of the radiation therapy oncology group clinical trials for head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;425-438.
29. Laramore GE, Stelzer KJ, Risler R, Schwartz JL, Douglas JJ, Einck JP, et al., Neutron capture therapy (NCT) enhancement of fast neutron radiotherapy: application to non-small cell lung cancer. In: Duggan JL, Morgan IL, editors, Proceedings of the Sixteenth International Conference on Application of Accelerators in Research and Industry. American Institute of Physics; 2001. p. 881-4.
30. Stelzer KJ, Gavin PR, Risler R, Kippenes H, Hawthorne MF, Nigg DW, et al. Boron neutron capture-enhanced fast neutron therapy (BNC/FNT) for non-small cell lung cancer in canine patients. In: Hawthorne MF, editor. Frontiers in neutron capture therapy. New York: Kluwer Academic/Plenum Publishers; 2001. p. 735-9.
31. 10 (GB-10) in human tumor patients. In: Monduzzi Editore, editor. Research and development in neutron capture therapy. Proceedings of the 10th International Congress on Neutron Capture Therapy. Bologna, Italy: Litosei-Rastignano; 2002. p. 993-9.
32. Nigg D.W., Wemple C.A., Risler R., Hartwell J.K., Harker Y.D., Laramore G.E. Modification of the University of Washington neutron radiotherapy facility for optimization of neutron capture enhanced fast-neutron therapy. Med. Phys. 27(2):2000;359-367.
33. Laramore G.E., Wootton P., Livesey J.C., Wilbur D.S., Risler R., Phillips M.et al. Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;1135-1142.
34. Stelzer K.J., Lindsley K.L., Cho P.S., Laramore G.E., Griffin T.W. Fast neutron radiotherapy: the University of Washington experience and potential use of concomitant boost with boron neutron capture. Radiation Protection Dosimetry. 70:1997;471-475.
35. Shklar G., Eisenberg E., Flynn E. Immunoenhancing agents and experimental leukoplakia and carcinoma of the buccal pouch. Prog. Exp. Tumor. Res. 24:1979;269-282.
36. Schwint A.E., Itoiz M.E., Cabrini R.L. A quantitative histochemical technique for the study of vascularization in tissue sections using horseradish peroxidase. Histochem. J. 16:1984;907-911.
37. Smith D.R., Chandra S., Barth R.F., Yang W., Joel D.D., Coderre J.A. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Cancer Res. 61:2001;8179-8187.
38. Patel H, Sedgwick EM. BPA & BSH accumulation in experimental tumors. In: Proceedings of the Ninth International Symposium on Neutron Capture Therapy for Cancer. Osaka, Japan; 2000. p. 59-60.
39. 10B boron neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation Int. J. Radiat. Oncol. Biol. Phys. 11:1985;831-840.
40. Ono K., Masunaga S., Kinashi Y., Tagaki M., Akaboshi M., Kobayashi T.et al. Radiobiological evidence suggesting heterogenous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int. J. Radiation. Oncol. Biol. Phys. 34:1996;1081-1086.
41. 11SH (BSH) in patients with malignant glioma as a precondition for boron neutron capture therapy (BNCT). Int. J. Radiat. Oncol. Biol. Phys. 28:1994;1175-1181.
42. 10B concentration for boron neutron capture therapy using prompt gamma-ray analysis Acta Oncol. 34:1995;517-523.
43. Joel D., Coderre J.A., Micca P.L., Nawrocky M.M. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy. J. Neuro-Oncol. 41:1999;213-221.
44. Laramore GE, Austin-Seymour M. Fast neutron radiotherapy in relation to the radiation sensitivity of human organ systems. In: Altman KI, Lett J, editors. Relative radiosensitivities of human organ systems, III. Advances in radiation biology, vol. 15. Orlando: Academic Press; 1992. p. 153-93.